Uroalerts Men's Health Weekly

May 26, 2026

Videos

Peer-to-Peer Clinical Conversations

Platelet-Rich Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis Investigates Efficacy - Helen Bernie

Helen Bernie

Helen Bernie presents a systematic review and meta-analysis of platelet-rich therapies for erectile dysfunction.

When to Consider Advanced Testing for Men with Lower Urinary Tract Symptoms - Hashim Hashim

Hashim Hashim

Hashim Hashim reviews video urodynamics indications for male lower urinary tract symptoms.

Beyond the Abstracts

Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Localised Prostate Cancer (HYPO-RT-PC): 10-Year Outcomes of an Open-Label, Randomised, Phase 3, Non-Inferiority Trial - Beyond the Abstract

Decoding the Heterogeneity of Human Undifferentiated Spermatogonia Reveals RAS-Dependent Regulation of Stem Cell Fate - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Androgen Deficiency

Worrying About Low Libido: A Mixed-Method Evaluation of Sexual Desire Across Gender, Sexual Orientation, and Relationship Status.

Male Infertility

Transgenerational exposure to plastics-derived endocrine-disrupting bisphenol A and its analogs on male infertility: impact of gut dysbiosis and epigenetic regulation.

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Intracytoplasmic sperm injection for non-male factor infertility does not improve cumulative live birth rate: a Canadian assisted reproductive technologies registry (CARTR Plus) descriptive study.

Peyronie's Disease

Development and validation of PEYRO-Q: a novel multidimensional patient-reported outcome measure for Peyronie's disease.

Prostatitis

Aquablation for dual burden disease - BPH and chronic prostatitis/chronic pelvic pain syndrome: a single-center prospective pilot study.

Erectile Dysfunction

Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management.

Evaluating mental health risk and psychiatric care access in 18-40 year old men with erectile dysfunction.

BPH - Benign Prostatic Enlargement

Comparison of Robotic vs Laser Enucleation of the Prostate for Treatment of Benign Prostatic Hyperplasia.

Quantitative CT biomarkers for predicting clinical outcomes after prostatic artery embolization: Results of the prospective pilot EMBOPERF study.

Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence.

Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median-Lobe Enlargement: A Single-Center Experience.

Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia.

Penile & Urethral Cancers

Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

Testicular Cancer

Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XR.

NFL's Alex Singleton and the Testicular Cancer Detection Gap.

Primary retroperitoneal lymph node dissection for clinical stage II seminoma: Comparative analysis against established paradigms using the National Cancer Data Base.

Residence Near Agricultural Crops at Birth and Risk of Adult Testicular Germ Cell Tumors: A French Nationwide Case-Control Study Using Historical Aerial GIS Data.

Prostate Cancer

Bladder activity of different PSMA PET radioligands and impact of furosemide.

Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer.

Focal Signet Ring-Like Prostate Adenocarcinoma Detected on Microultrasound in the Setting of Negative Multiparametric Magnetic Resonance Imaging: A Case Report.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Improving physical activity in men with prostate cancer through wearable devices and online education: Randomized controlled trial.

Baseline PSMA-ligand PET/CT as a predictive biomarker for early progression in metastatic castration-resistant prostate cancer patients undergoing [177Lu]Lu-PSMA-617 radioligand therapy.

Radioligand Therapy Hormone Combinations and the ENZA-p Trial.

Elective Nodal Radiotherapy in Localized Prostate Cancer: A Meta-Analysis.

Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes.

Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer.

Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial.

Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer.

Transforming postoperative follow-up: telemedicine trends in radical prostatectomy patients.

Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.

Real-World Representation in Prostate Cancer Clinical Trials: Needs and Opportunities.

A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.

Radiochemistry and comparative in vitro assessment of PSMA-617 labeled with lead-212 (212Pb), actinium-225 (225Ac), and lutetium-177 (177Lu).

Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature.

Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience.

The predictive role of [177Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysis.

GMP-compliant automated synthesis and quality control of [177Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer.

Marital status and post-radical prostatectomy outcomes: results from the SEARCH database.

From 18F-choline to prostate-specific membrane antigen PET: lessons from early multiparametric kinetic modelling in prostate cancer.

The evolving PI-RADS paradigm.

The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis.

Intra-fraction target motion during MR-guided prostate stereotactic body radiotherapy: the importance of adaptive planning and real-time motion management.

Phase II Trial of Combination Radiation, Hormone, and Immunotherapy in Grade Group 5 Prostate Cancer - Beyond the Abstract

Therapeutic Targeting of Prostate-Specific Membrane Antigen Could Limit Its Potential as Benchmark Imaging - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC